Strs Ohio Beam Therapeutics Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Strs Ohio holds 7,200 shares of BEAM stock, worth $208,872. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,200

Previous 7,200 -0.0%

Holding current value

$208,872

Previous $168,000 4.76%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$21.22 - $32.66 $120,954 - $186,161	5,700 Added 380.0%	7,200 $168,000
Q1 2024 May 13, 2024	BUY	$23.46 - $45.07 $35,190 - $67,605	1,500 New	1,500 $49,000
Q1 2023 Aug 02, 2023	BUY	$30.15 - $48.79 $153,765 - $248,829	5,100 New	5,100 $156,000
Q4 2022 Jan 26, 2023	SELL	$36.73 - $51.6 $29,383 - $41,280	-800 Reduced 13.56%	5,100 $199,000
Q3 2022 Oct 27, 2022	BUY	$39.79 - $70.31 $111,412 - $196,868	2,800 Added 90.32%	5,900 $281,000
Q2 2022 Jul 25, 2022	BUY	$29.86 - $62.36 $62,706 - $130,956	2,100 Added 210.0%	3,100 $120,000
Q1 2022 Apr 21, 2022	SELL	$53.73 - $82.16 $112,833 - $172,536	-2,100 Reduced 67.74%	1,000 $57,000
Q4 2021 Jan 24, 2022	SELL	$68.02 - $99.06 $469,338 - $683,514	-6,900 Reduced 69.0%	3,100 $247,000
Q3 2021 Oct 22, 2021	SELL	$84.37 - $133.6 $75,933 - $120,240	-900 Reduced 8.26%	10,000 $870,000
Q2 2021 Jul 26, 2021	BUY	$64.12 - $128.71 $256,480 - $514,840	4,000 Added 57.97%	10,900 $1.4 Million
Q1 2021 Apr 23, 2021	BUY	$71.28 - $120.75 $342,144 - $579,600	4,800 Added 228.57%	6,900 $552,000
Q4 2020 Jan 25, 2021	BUY	$22.24 - $95.63 $46,704 - $200,823	2,100 New	2,100 $171,000
Q2 2020 Jul 23, 2020	SELL	$15.26 - $28.66 $47,306 - $88,846	-3,100 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$13.31 - $29.2 $41,261 - $90,520	3,100 New	3,100 $55,000

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.04B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account